 | • レポートコード：GIR-2104Z07121 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、HIVポイントオブケア検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。HIVポイントオブケア検査の種類別市場規模（検査装置、検査試薬）、用途別市場規模（病院、診療所、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・HIVポイントオブケア検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、BD、Biomerieux、Adaltis、Roche ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：検査装置、検査試薬 ・用途別分析2016年-2026年：病院、診療所、在宅ケア ・HIVポイントオブケア検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・HIVポイントオブケア検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・HIVポイントオブケア検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・HIVポイントオブケア検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・HIVポイントオブケア検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The HIV Point-of-care Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global HIV Point-of-care Testing size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global HIV Point-of-care Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
HIV Point-of-care Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Testing Equipment
Testing Reagent
Market segment by Application can be divided into
Hospitals
Clinics
Home Care Setting
The key market players for global HIV Point-of-care Testing market are listed below:
Abbott
BD
Biomerieux
Adaltis
Roche
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 HIV Point-of-care Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global HIV Point-of-care Testing Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Testing Equipment
1.2.3 Testing Reagent
1.3 Market Analysis by Application
1.3.1 Overview: Global HIV Point-of-care Testing Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Setting
1.4 Global HIV Point-of-care Testing Market Size & Forecast
1.4.1 Global HIV Point-of-care Testing Sales in Value (2016-2026))
1.4.2 Global HIV Point-of-care Testing Sales in Volume (2016-2026)
1.4.3 Global HIV Point-of-care Testing Price by Type (2016-2026) & (USD/Unit)
1.5 Global HIV Point-of-care Testing Production Capacity Analysis
1.5.1 Global HIV Point-of-care Testing Total Production Capacity (2016-2026)
1.5.2 Global HIV Point-of-care Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 HIV Point-of-care Testing Market Drivers
1.6.2 HIV Point-of-care Testing Market Restraints
1.6.3 HIV Point-of-care Testing Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott HIV Point-of-care Testing Product and Services
2.1.4 Abbott HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD HIV Point-of-care Testing Product and Services
2.2.4 BD HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biomerieux
2.3.1 Biomerieux Details
2.3.2 Biomerieux Major Business
2.3.3 Biomerieux HIV Point-of-care Testing Product and Services
2.3.4 Biomerieux HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Adaltis
2.4.1 Adaltis Details
2.4.2 Adaltis Major Business
2.4.3 Adaltis HIV Point-of-care Testing Product and Services
2.4.4 Adaltis HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche HIV Point-of-care Testing Product and Services
2.5.4 Roche HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 HIV Point-of-care Testing Sales by Manufacturer
3.1 Global HIV Point-of-care Testing Sales in Volume by Manufacturer (2019-2021e)
3.2 Global HIV Point-of-care Testing Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in HIV Point-of-care Testing
3.4 Market Concentration Rate
3.4.1 Top 3 HIV Point-of-care Testing Manufacturer Market Share
3.4.2 Top 6 HIV Point-of-care Testing Manufacturer Market Share
3.5 Global HIV Point-of-care Testing Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and HIV Point-of-care Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global HIV Point-of-care Testing Market Size by Region
4.1.1 Global HIV Point-of-care Testing Sales in Volume by Region (2016-2026)
4.1.2 Global HIV Point-of-care Testing Revenue by Region (2016-2026)
4.2 North America HIV Point-of-care Testing Revenue (2016-2026)
4.3 Europe HIV Point-of-care Testing Revenue (2016-2026)
4.4 Asia-Pacific HIV Point-of-care Testing Revenue (2016-2026)
4.5 South America HIV Point-of-care Testing Revenue (2016-2026)
4.6 Middle East and Africa HIV Point-of-care Testing Revenue (2016-2026)
5 Market Segment by Type
5.1 Global HIV Point-of-care Testing Sales in Volume by Type (2016-2026)
5.2 Global HIV Point-of-care Testing Revenue by Type (2016-2026)
5.3 Global HIV Point-of-care Testing Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global HIV Point-of-care Testing Sales in Volume by Application (2016-2026)
6.2 Global HIV Point-of-care Testing Revenue by Application (2016-2026)
6.3 Global HIV Point-of-care Testing Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America HIV Point-of-care Testing Sales by Type (2016-2026)
7.2 North America HIV Point-of-care Testing Sales by Application (2016-2026)
7.3 North America HIV Point-of-care Testing Market Size by Country
7.3.1 North America HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
7.3.2 North America HIV Point-of-care Testing Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe HIV Point-of-care Testing Sales by Type (2016-2026)
8.2 Europe HIV Point-of-care Testing Sales by Application (2016-2026)
8.3 Europe HIV Point-of-care Testing Market Size by Country
8.3.1 Europe HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
8.3.2 Europe HIV Point-of-care Testing Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific HIV Point-of-care Testing Sales by Type (2016-2026)
9.2 Asia-Pacific HIV Point-of-care Testing Sales by Application (2016-2026)
9.3 Asia-Pacific HIV Point-of-care Testing Market Size by Region
9.3.1 Asia-Pacific HIV Point-of-care Testing Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific HIV Point-of-care Testing Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America HIV Point-of-care Testing Sales by Type (2016-2026)
10.2 South America HIV Point-of-care Testing Sales by Application (2016-2026)
10.3 South America HIV Point-of-care Testing Market Size by Country
10.3.1 South America HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
10.3.2 South America HIV Point-of-care Testing Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa HIV Point-of-care Testing Sales by Type (2016-2026)
11.2 Middle East & Africa HIV Point-of-care Testing Sales by Application (2016-2026)
11.3 Middle East & Africa HIV Point-of-care Testing Market Size by Country
11.3.1 Middle East & Africa HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa HIV Point-of-care Testing Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 HIV Point-of-care Testing Typical Distributors
12.3 HIV Point-of-care Testing Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global HIV Point-of-care Testing Revenue by Type, (USD Million), 2021-2026
Table 2. Global HIV Point-of-care Testing Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott HIV Point-of-care Testing Product and Services
Table 6. Abbott HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BD Basic Information, Manufacturing Base and Competitors
Table 8. BD Major Business
Table 9. BD HIV Point-of-care Testing Product and Services
Table 10. BD HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biomerieux Basic Information, Manufacturing Base and Competitors
Table 12. Biomerieux Major Business
Table 13. Biomerieux HIV Point-of-care Testing Product and Services
Table 14. Biomerieux HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Adaltis Basic Information, Manufacturing Base and Competitors
Table 16. Adaltis Major Business
Table 17. Adaltis HIV Point-of-care Testing Product and Services
Table 18. Adaltis HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche HIV Point-of-care Testing Product and Services
Table 22. Roche HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global HIV Point-of-care Testing Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global HIV Point-of-care Testing Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in HIV Point-of-care Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global HIV Point-of-care Testing Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and HIV Point-of-care Testing Production Site of Key Manufacturer
Table 28. Global HIV Point-of-care Testing Sales by Region (2016-2021e) & (K Units)
Table 29. Global HIV Point-of-care Testing Sales by Region (2021-2026) & (K Units)
Table 30. Global HIV Point-of-care Testing Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global HIV Point-of-care Testing Revenue by Region (2021-2026) & (USD Million)
Table 32. Global HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 33. Global HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 34. Global HIV Point-of-care Testing Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global HIV Point-of-care Testing Revenue by Type (2021-2026) & (USD Million)
Table 36. Global HIV Point-of-care Testing Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global HIV Point-of-care Testing Price by Type (2021-2026) & (USD/Unit)
Table 38. Global HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 39. Global HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 40. Global HIV Point-of-care Testing Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global HIV Point-of-care Testing Revenue by Application (2021-2026) & (USD Million)
Table 42. Global HIV Point-of-care Testing Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global HIV Point-of-care Testing Price by Application (2021-2026) & (USD/Unit)
Table 44. North America HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 45. North America HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 46. North America HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 48. North America HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 49. North America HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 50. North America HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 51. North America HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 52. Europe HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 53. Europe HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 54. Europe HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 57. Europe HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 58. Europe HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 59. Europe HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific HIV Point-of-care Testing Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific HIV Point-of-care Testing Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific HIV Point-of-care Testing Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific HIV Point-of-care Testing Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 68. South America HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 69. South America HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 70. South America HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 72. South America HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 73. South America HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 74. South America HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 75. South America HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. HIV Point-of-care Testing Typical Distributors
Table 87. HIV Point-of-care Testing Typical Customers
List of Figures
Figure 1. HIV Point-of-care Testing Picture
Figure 2. Global HIV Point-of-care Testing Sales Market Share by Type in 2020
Figure 3. Testing Equipment
Figure 4. Testing Reagent
Figure 5. Global HIV Point-of-care Testing Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Home Care Setting
Figure 9. Global HIV Point-of-care Testing Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global HIV Point-of-care Testing Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global HIV Point-of-care Testing Sales (2016-2026) & (K Units)
Figure 31. Global HIV Point-of-care Testing Production Capacity (2016-2026) & (K Units)
Figure 32. Global HIV Point-of-care Testing Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. HIV Point-of-care Testing Market Drivers
Figure 34. HIV Point-of-care Testing Market Restraints
Figure 35. HIV Point-of-care Testing Market Trends
Figure 36. Global HIV Point-of-care Testing Sales Market Share by Manufacturer in 2020
Figure 37. Global HIV Point-of-care Testing Revenue Market Share by Manufacturer in 2020
Figure 38. HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 HIV Point-of-care Testing Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 HIV Point-of-care Testing Manufacturer (Revenue) Market Share in 2020
Figure 41. Global HIV Point-of-care Testing Sales Market Share by Region (2016-2026)
Figure 42. Global HIV Point-of-care Testing Revenue Market Share by Region (2016-2026)
Figure 43. North America HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 44. Europe HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 46. South America HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 48. Global HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 49. Global HIV Point-of-care Testing Revenue Market Share by Type (2016-2026)
Figure 50. Global HIV Point-of-care Testing Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 52. Global HIV Point-of-care Testing Revenue Market Share by Application (2016-2026)
Figure 53. Global HIV Point-of-care Testing Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 55. North America HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 56. North America HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 57. North America HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 58. Europe HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 59. Europe HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 60. Europe HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 61. Europe HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific HIV Point-of-care Testing Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific HIV Point-of-care Testing Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific HIV Point-of-care Testing Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 66. South America HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 67. South America HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 68. South America HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 69. South America HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のポイントオブケア検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point of Care Testing Market The global Point of Care Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…- 世界のポイントオブケア検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point of Care Testing Market The global Point of Care Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界のポイントオブケア凝固検査市場規模・現状・予測（2021年-2027年） POCT, also called near-patient testing, is performed outside a clinical laboratory. The increasing penetration of POCT devices in developed countries is one of the significant factors driving the growth of this market. Market Analysis and Insights: Global Point-of-Care Coagulation Testing Market The…
- 世界のポイントオブケア遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point-of-Care Genetic Testing Market The global Point-of-Care Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のポイントオブケア（POCT）検査市場 2021：企業別、地域別、種類・用途別 The Point of Care Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…